Rafael Moreno-Sánchez Selected Research

casiopeina II-glycine

1/2018	Energy Metabolism Drugs Block Triple Negative Breast Metastatic Cancer Cell Phenotype.
2/2013	Reactive oxygen species are generated by the respiratory complex II--evidence for lack of contribution of the reverse electron flow in complex I.
5/2012	Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation.
9/2006	Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rafael Moreno-Sánchez Research Topics

Disease

46	Neoplasms (Cancer) 01/2021 - 06/2003
10	Hepatocellular Carcinoma (Hepatoma) 11/2020 - 06/2003
10	Hypoxia (Hypoxemia) 01/2018 - 08/2009
7	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2013
6	Carcinoma (Carcinomatosis) 01/2022 - 12/2009
6	Neoplasm Metastasis (Metastasis) 11/2019 - 08/2009
4	Carcinogenesis 11/2019 - 10/2007
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2020 - 08/2015
3	Hypoglycemia (Reactive Hypoglycemia) 10/2017 - 08/2014
2	Chromate Resistance 09/2009 - 07/2002
2	Heart Diseases (Heart Disease) 10/2007 - 03/2003
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Dysbiosis 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Chagas Disease (American Trypanosomiasis) 01/2019
1	Polyps 01/2019
1	Melanoma (Melanoma, Malignant) 01/2018
1	Hand-Foot Syndrome 01/2018
1	Ascites 01/2016
1	Triple Negative Breast Neoplasms 12/2014

Drug/Important Bio-Agent (IBA)

17	Adenosine Triphosphate (ATP)IBA 01/2022 - 03/2003
17	Proteins (Proteins, Gene)FDA Link 10/2018 - 09/2009
16	EnzymesIBA 11/2020 - 03/2003
11	Pharmaceutical PreparationsIBA 12/2020 - 08/2009
10	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 03/2003
8	HexokinaseIBA 01/2016 - 05/2006
6	GlycogenIBA 11/2020 - 11/2010
6	Succinic Acid (Succinate)IBA 01/2019 - 06/2003
5	Celecoxib (Celebrex)FDA Link 01/2022 - 01/2018
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2020 - 01/2009
5	IsomerasesIBA 11/2020 - 05/2014
4	Biomarkers (Surrogate Marker)IBA 11/2019 - 10/2011
4	OligomycinsIBA 01/2018 - 06/2003
4	casiopeina II-glycineIBA 01/2018 - 09/2006
4	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2016 - 08/2009
4	Protein Isoforms (Isoforms)IBA 08/2014 - 08/2009
4	Oxygen (Dioxygen)IBA 08/2013 - 08/2009
3	Cisplatin (Platino)FDA LinkGeneric 12/2020 - 01/2009
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 01/2009
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2020 - 01/2009
3	NADP (NADPH)IBA 11/2020 - 11/2017
3	Adenosine Diphosphate (ADP)IBA 01/2020 - 07/2008
3	Transcription Factors (Transcription Factor)IBA 10/2019 - 08/2009
3	Phosphates (Orthophosphate)IBA 01/2019 - 06/2014
3	GossypolIBA 06/2017 - 09/2006
3	Messenger RNA (mRNA)IBA 01/2016 - 10/2010
3	Lactic Acid (Lactate)FDA LinkGeneric 06/2014 - 05/2012
3	alpha-Tocopherol FDA Link 02/2013 - 02/2011
3	Antineoplastic Agents (Antineoplastics)IBA 05/2012 - 04/2006
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2019 - 11/2011
2	AntioxidantsIBA 01/2019 - 02/2015
2	Glutathione Disulfide (GSSG)FDA LinkGeneric 10/2018 - 11/2017
2	TeaIBA 01/2018 - 09/2012
2	Lactate Dehydrogenase 5IBA 01/2018 - 08/2009
2	CytokinesIBA 10/2017 - 06/2014
2	6-phosphogluconic acidIBA 10/2017 - 06/2014
2	Pyruvate KinaseIBA 01/2016 - 08/2014
2	Oxidoreductases (Dehydrogenase)IBA 01/2016 - 06/2003
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2016 - 05/2006
2	Phosphofructokinase-1 (Phosphofructokinase 1)IBA 05/2014 - 05/2006
2	Ketoglutaric Acids (Ketoglutaric Acid)IBA 05/2014 - 06/2003
2	Fatty Acids (Saturated Fatty Acids)IBA 05/2014 - 03/2003
2	Glutamine (L-Glutamine)FDA Link 05/2014 - 09/2006
2	Vitamin E FDA LinkGeneric 09/2012 - 11/2011
2	CopperIBA 05/2012 - 04/2006
2	Biological ProductsIBA 11/2011 - 02/2011
2	Hypoglycemic Agents (Hypoglycemics)IBA 06/2011 - 10/2007
2	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 10/2010 - 08/2009
2	ChromatesIBA 09/2009 - 07/2002
1	Acetates (Acetic Acid Esters)FDA Link 01/2021
1	Carboxylic AcidsIBA 01/2021
1	PhosphoglucomutaseIBA 11/2020
1	Glutamate DehydrogenaseIBA 01/2020
1	Leucine (L-Leucine)FDA Link 01/2020
1	Auranofin (Ridaura)FDA Link 11/2019
1	Protein Kinases (Protein Kinase)IBA 10/2019
1	Phosphotransferases (Kinase)IBA 03/2019
1	Ataxia Telangiectasia Mutated ProteinsIBA 03/2019
1	PolyphosphatesIBA 01/2019
1	PeroxidesIBA 01/2019
1	Sulfhydryl Compounds (Thiols)IBA 01/2019
1	ResveratrolIBA 01/2019
1	trypanothioneIBA 01/2019
1	MetalsIBA 01/2019
1	Superoxides (Superoxide)IBA 01/2018
1	Capecitabine (Xeloda)FDA Link 01/2018
1	Aminooxyacetic AcidIBA 01/2017
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2016
1	HexosesIBA 01/2016
1	Dihydroxyacetone PhosphateIBA 01/2016
1	Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA 01/2016
1	CholesterolIBA 08/2015
1	NAD (NADH)IBA 08/2015
1	Nonesterified Fatty Acids (NEFA)IBA 08/2015
1	PerhexilineIBA 08/2015
1	Mitochondrial Permeability Transition PoreIBA 02/2015
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2015

Therapy/Procedure

13	Therapeutics 12/2020 - 10/2007
4	Drug Therapy (Chemotherapy) 11/2019 - 03/2007
1	Immunotherapy 11/2019